Filing Details
- Accession Number:
- 0001104659-24-002584
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-09 16:03:59
- Reporting Period:
- 2024-01-05
- Accepted Time:
- 2024-01-09 16:03:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1951861 | Daniel Calkins | C/O Verastem, Inc., 117 Kendrick St., Suite 500 Needham MA 02494 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-01-05 | 6 | $8.50 | 8,621 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
- Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan.